AcquisitionOther

Mallinckrodt plc acquired Par Health (generic pharmaceuticals and sterile injectables businesses)

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Mallinckrodt plc -> Par Health (generic pharmaceuticals and sterile injectables businesses) · $1.7 billion pro-forma combined revenue

Creating new focused company Keenova to develop branded therapeutics for patients with rare or unaddressed conditions.